Achieving Health Equity Requires Transformational Change
This activity has been archived and credit is no longer available.
In this presentation, Dr. Kim Rhoads discusses the necessary steps institutions must take to achieve health equity and reviews the limitations of the traditional approach to addressing health disparities. She also reflects on the concept of "otherization" of minority groups in healthcare, education, and other societal institutions and how this perpetuates inequalities.
This Center of Excellence in Health Equity, Training and Research Grand Rounds session took place on Tuesday, September 28, 2021 at 12:00 P.M. and has been approved for Ethics Credit.
Activity Information
This activity has been archived and credit is no longer available.
Needs Statement
Physicians, residents, fellows, medical students and other healthcare providers across practice areas encounter health care equity issues such as health disparities, social determinants of health, cultural/linguistic competencies, and social justice. The series aims to broaden the awareness of learners in these topic areas provide strategies to address these issues as they arise.
Educational Objectives
At the conclusion of this activity, the participant should be able to:
- Demonstrate greater understanding of the underpinnings of health disparities in the United States healthcare system.
- Identify opportunities for institution-level structural changes to promote health equity and develop strategies to exploit those opportunities.
- Apply best practices when partnering with the community to eliminate health disparities.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Nurses
- Other Health Professionals
Specialties
Interest Groups
- Equity, Diversity, and Inclusion
- Ethics
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been designated by Baylor College of Medicine for 1 credit of education in medical ethics and/or professional responsibility.
Activity Director
Term of Approval
September 1, 2021 through September 30, 2023. Original release date: September 1, 2021.
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Kim Rhoads, M.D., M.S., M.P.H.
Associate Professor
University of California San Francisco School of Medicine
Disclosure:
- Ownership Interests (stock, stock options, excluding diversified mutual funds): Immutep Biotechnology (Company Stock)
Activity Director
-
Jean L. Raphael, M.D., M.P.H.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Toi Blakely Harris, M.D.
Professor and Associate Provost
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Michelle A. Lopez, M.D., M.P.H.
Assistant Professor of Pediatrics
Baylor College of Medicine
Disclosure:
- Research Support: Merck
-
Erik D. Malmberg, Ph.D., J.D.
Assistant Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Jean L. Raphael, M.D., M.P.H.
Associate Professor
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Health Topics
Presenter: